Mill Creek Life Sciences announces receipt of a grant during the inaugural round of funding from Regenerative Medicine Minnesota.
Featured Article
Mill Creek Life Sciences announces receipt of a grant during the inaugural round of funding from Regenerative Medicine Minnesota.
With favorable regenerative and immunotolerant profiles, patient-derived human mesenchymal stem cells (hMSCs) are increasingly considered in cell therapy.
Research grade PLTMax® and PLTGold® are available from LAgen Laboratories in the 100mL bottle size.